CO-EDITORS
Dr. Dean Elterman, MD, MSc, FRCSC
Lang Family Endowed Chair in Urologic Innovation
Associate Professor of Urology, Department of Surgery, University of Toronto
Urologic Surgeon, Division of Urology, University Health Network
Fellowship Director, Functional Urology, Toronto Western Hospital
Clinician Investigator, Krembil Research Institute, University Health Network
Toronto, Canada
Chair, SIU Innovators, Société Internationale d'Urologie
Disclosures: Astellas, Boston Scientific, Laborie, Medtronic, Olympus, Pierre Fabre Médicament, PROCEPT BioRobotics
Prof. Stavros Gravas, MD, PhD, FEBU
Professor of Urology, Medical School, University of Cyprus, Nicosia, Cyprus
General Secretary, Société Internationale d'Urologie
Disclosures: Grants/research support from Pierre Fabre Médicament; honoraria or consultation fees from Astellas, GSK, Pierre Fabre Médicament.
Prof. Andrea Tubaro, MD, FEBU
Professor of Urology, Sapienza University of Rome
Chairman, Department of Urology, Sant'Andrea Hospital
Rome, Italy
Disclosures: Receipt of grants/research supports: Johnson&Johnson
Receipt of honoraria or consultation fees: Bayer
Participation in a company sponsored speaker’s bureau: Novo Nordisk
Spouse/partner: Sanofi
COMMITTEE 1: Lower Urinary Tract Symptoms in Men
CO-CHAIRS
Prof. Karel C.M.M. Everaert, MD, PhD
Professor Functional Urology & Chairman, Sector “Man–Woman– Child”, Professor of Neurourology, Department of Urology , Ghent University & Ghent University Hospital (UZ Gent), Ghent, Belgium
Disclosures: Grants/research support from Astellas, Metronic; honoraria or consultation fees from Astellas, Ferring; Participation in a company sponsored speaker’s bureau for Astellas, Ferring.
Prof. Philip E.V. van Kerrebroeck, MD, PhD, MMSc
Professor of Urology
Maastricht University & Maastricht University Medical Centre (MUMC+)
Maastricht, Limburg, The Netherlands
Former Chairman, Department of Urology, Maastricht University Hospital (1997–2012)
Vice Chair, EU Policy Office, European Association of Urology (since 2021)
Disclosures:
COMMITTEE MEMBERS
Jeff M. Weiss, MD, PhD, FACS
Professor and Chair, Department of Urology, Director, MD-PhD Program, School of Graduate Studies, SUNY Downstate Health Sciences University, Brooklyn, New York, United States
Disclosures: None
Craig Comiter, MD
Professor of Urology, Department of Urology, Stanford University School of Medicine, Stanford, California, United States
Disclosures: None
Carlos Arturo Levi D'Ancona, MD, MSc, PhD
Full Professor of Urology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
Disclosures: None
Salvador Arlandis, MD, PhD
Head, Reconstructive and Functional Urology Section, Department of Urology, La Fe University and Polytechnic Hospital. Valencia; Associate Professor of Urology, University of Valencia, Valencia, Spain
Disclosures: Grants/research support from Boston Scientific, Coloplast; honoraria or consultation feed from Astellas, Boston Scientific, Medtronic; participation in a company sponsored speaker’s bureau for Apogepha, Astellas, Pierre Fabre Médicament.
Sanjay Sinha, MBBS, MS, DNB, MCh, MD
Honorary Professor & Senior Consultant Urologist, Apollo Hospitals (Hyderguda & Jubilee Hills), Hyderabad, Telangana, India
Disclosures: Speaker honorarium: Cipla, MSN, Sun, DRL, IPCA, Alkem); Equity (UnivLabs)
George Bou Kheir, MD, PhD
Functional Urologist, Department of Urology, Ghent University Hospital, ERN-Accredited Center, Ghent, Belgium
Disclosures: None
Cassandra Heaney, MD
Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, New York, United States
Disclosures: None
COMMITTEE 2: Patient Assessment
CHAIR
Marcus J. Drake, DM, FRCS (Urol)
Professor and Chair in Neurological Urology, Department of Surgery & Cancer, Imperial College London, London; Honorary Consultant Urologist, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
Disclosures: Receipt of honoraria or consultation fees: Astellas, Minze/ Medtronic, Viatris
Participation in a company sponsored speaker’s bureau: Astellas, Pierre Fabre
COMMITTEE MEMBERS
Marcio A. Averbeck, MD, MSc, PhD
Urologist Head of Neuro-Urology, Moinhos de Vento Hospital (Johns Hopkins Affiliated), Porto Alegre; Preceptor of the Urology Residency Program, São Lucas Hospital, Pontifical Catholic University of RS (PUCRS), Porto Alegre, Brazil
Disclosures: None
Alex Ciudin, MD, PhD, FEBU
Head of the Pelvic Floor Unit, Department of Urology, Hospital Universitari de Mollet, Barcelona, Spain
Disclosures: None
Enrico Finazzi-Agrò, MD
Full Professor, Department of Urology, University of Rome “Tor Vergata,” Rome; Chair, Department of Urology, Policlinico Tor Vergata University Hospital, Rome; Head, Functional Urology Service & Mini Invasive Urological Surgery Unit, Tor Vergata General Hospital, Rome, Italy
Disclosures: Grants/research support from Laborie; honoraria or consultation fees from Recordati, Pierre Fabre Médicament, Convatec; participation in a company sponsored speaker’s bureau for Pierre Fabre Médicament
William Gibson, MBChB(MD), PhD, FRCP
Associate Professor, Division of Geriatric Medicine, University of Alberta, Edmonton, Alberta, Canada
Disclosures:
Hiroki Ito, MD, PhD
Professor, Fukushima Medical University, Fukushima City, Fukushima Prefecture, Japan
Disclosures:
Filipe Abadesso Lopes, MD
Serviço de Urologia, ULS Santa Maria, Lisbon, Portugal
Disclosures: None
Paulina Bueno-Garcia-Reyes, MD
Urology Department, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico
Disclosures: None
Ricardo Pereira e Silva, MD, FEBU
Hospital de Santa Maria, ULS Santa Maria, Lisbon, Portugal; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal
Disclosures: None
Qi-Xiang Song, MD, PhD
Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Disclosures: None
John E. Speich, PhD
Professor, Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University College of Engineering, Richmond, Virginia, United States
Disclosures: Receipt of grants/research supports: US National Institutes of Health
Stock shareholder: Vesi Corporation
Tufan Tarcan, MD, PhD
Professor of Urology, Department of Urology, Marmara University School of Medicine, Istanbul; Department of Urology, Koç University School of Medicine, Istanbul, Turkey
Disclosures: Consultancy for or receipt of speaker's fees: Viatris, Nobel, Laborie, Recordati, Eczacıbaşı, Abdi Ibrahim, Aymed İlaç
COMMITTEE 3: Lifestyle Intervention and Pharmacological Treatments
CHAIR
Prof. Andrea Tubaro, MD, FEBU
Professor of Urology, Sapienza University of Rome; Chairman, Department of Urology, Sant'Andrea Hospital, Rome, Italy
Disclosures: Receipt of grants/research supports: Johnson&Johnson
Receipt of honoraria or consultation fees: Bayer
Participation in a company sponsored speaker’s bureau: Novo Nordisk
Spouse/partner: Sanofi
COMMITTEE MEMBERS
Mélanie Aubé-Peterkin, MD
Assistant Professor, Division of Urology, Department of Surgery, McGill University Health Centre (MUHC), Montreal, Quebec, Canada
Disclosures: None
Marcus J. Drake, DM, FRCS (Urol)
Professor and Chair in Neurological Urology, Department of Surgery & Cancer, Imperial College London, London, United Kingdom
Disclosures:
Ferdinando Fusco, MD, PhD
Associate Professor of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy
Disclosures: None
Prof. Stavros Gravas, MD, PhD, FEBU
Professor of Urology, Medical School, University of Cyprus, Nicosia, Cyprus; General Secretary, Société Internationale d'Urologie
Disclosures: Grants/research support from Pierre Fabre Médicament; honoraria or consultation fees from Astellas, GSK, Pierre Fabre Médicament.
Sender Herschorn, MD
Professor, Division of Urology, Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
Disclosures: Receipt of grants/research supports: Lilly, Abbvie
Receipt of honoraria or consultation fees: Abbvie
Souhil Lebdai, MD, PhD
Professor, Urology Department, CHU d'Angers, Angers, France
Disclosures: Consultant for Pierre Fabre, Proctor for Teleflex, Proctor for Boston Scientific
Yoshihisa Matsukawa, MD, PhD
Associate Professor, Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Disclosures: None
Petros Sountoulides, MD, PhD, MSc, FEBU
Associate Professor of Urology, 1st Urology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
Disclosures: None
Christos Roidos, MD, MSc
Associate Professor of Urology, 1st Urology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
Disclosures: None
COMMITTEE 4: Invasive Surgical Treatments
CO-CHAIRS
Prof. Peter Gilling, CNZM, MD, FRACS
Professor of Surgery, University of Auckland, Auckland, New Zealand; Urologist, Urology Bay of Plenty / Grace Hospital, Tauranga, New Zealand
Disclosures: Receipt of grants/research supports: Procept Biorobotics Ltd (past), Rivermark Medical Ltd, Resurge Therapeutics, Zenflow lnc (past), Andromeda Surgical
Prof. Henry Woo, MBBS, DMedSc, FRACS(Urol), FACS
Professor of Urology, Australian National University, Canberra, Australian Capital Territory, Australia; Director, SAN Prostate Centre of Excellence, Sydney Adventist Hospital, Wahroonga, New South Wales; Professor of Robotic Cancer Surgery, Chris O’Brien Lifehouse, Camperdown, New South Wales, Australia
Disclosures: Advisory board or educational activities for Astellas, Boston Scientific, Ferring
COMMITTEE MEMBERS
Lori Lerner, MD
Associate Professor of Urology, Boston University School of Medicine, Chief of Urology and Deputy Chief Surgical Service, VA Boston Healthcare System, Boston, Massachusetts, United States
Disclosures: None
Akhil Das, MD, FACS
Professor of Urology, Department of Urology, University of California Irvine, Orange, California, United States
Disclosures:
Tevita Aho, FRACS(Urol), FRCS(Eng)
Cambridge University Hospitals NHS Foundation Trust, Cambridge and The Princess Grace Hospital, London, United Kingdom
Disclosures: None
Naeem Bhojani, MD
Centre Hospitalier de l'Université de Montréal, Montreal, Canada
Disclosures: Honoraria or consultation fees for Boston Scientific, Laborie, Olympus, PROCEPT BioRobotics.
Luca Cindolo, MD, PhD, FEBU
Centro Urologico Europeo, Modena, Italy
Disclosures: None
Jullet Han, MD
Assistant Professor of Clinical Urology, University of Southern California, Los Angeles, California, United States
Disclosures: None
Christopher Kelly, MD
Assistant Professor, Department of Urology, NYU Grossman School of Medicine; Urologist, NYU Langone Health; Attending Urologist, NYC Health + Hospitals/Bellevue, New York, New York, United States
Disclosures:
COMMITTEE 5: BPH Minimally Invasive Treatments
CO-CHAIRS
Bradley C. Gill, MD, MS
Associate Professor, Urology; Chief of Surgery, Cleveland Clinic Hillcrest & Mentor Hospitals; Director of Innovation, Department of Urology, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, United States
Disclosures: Consultant/advisor for Boston Scientific, Sumitomo Pharma America
Kevin C. Zorn, MD, FRCSC, FACS
Founder of BPH Canada, Director of Robotic & MIS BPH Prostate Surgery Institute, Mont-Royal Surgical Center, Montreal, Canada
Disclosures: Consultant for PROCEPT BioRobotics, Boston Scientific, Zenflow, Laborie
COMMITTEE MEMBERS
Charles Welliver, MD
Associate Professor of Surgery, Division of Urology, Albany Medical College, Albany, New York, United States
Disclosures: None
Johnny Su, MD
Urologist, Houston Methodist Urology Associates, Houston, Texas, United States
Disclosures:
Prof. Bhaskar K. Somani, MBBS, FRCS (Urol), FEBU
Professor of Urology, University Hospital Southampton NHS Foundation Trust, Southhampton, United Kingdom
Disclosures: None
Silvia Secco, MD
Niguarda Hospital, Milan, Italy
Disclosures: Proctor for Teleflex, Olympus, Boston Scientific, PROCEPT BioRobotics, abMedica, Medtronic; lecturer for Teleflex, Olympus, Boston Scientific, PROCEPT BioRobotics, abMedica; advisory board for Teleflex, Olympus, Boston Scientific, PROCEPT BioRobotics
Andrew Rosenzweig, MD
Physician Advisor/Medical Director of Clinical Operations, Abington Hospital - Jefferson Health, Abington, Pennsylvania; Clinical Assistant Professor of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Disclosures:
Jennifer Polo, MD
Donald and Barbara Zucker School of Medicine at Hofstra Northwell Health, Syosset, New York, United States
Disclosures: None
Obinna Obuekwe, MD
Andrology Research Fellow at Houston Methodist, Houston, Texas, United States
Disclosures: None
Mattia Longoni, MD
Urology Resident, IRCCS Ospedale San Raffaele, Milan, Italy
Disclosures: None
Ricardo R. Gonzalez, MD
Houston Methodist, Houston, Texas, United States
Disclosures: Receipt of grants/research supports: Butterfly Medical, Laborie, Prodeon Medical, Proverum, Rivermark Medical, Zenflow. Receipt of honoraria or consultation fees: Boston Scientific Stock shareholder: Procept Biorobotics
Dean Elterman, MD, MSc, FRCSC
Lang Family Endowed Chair in Urologic Innovation; Associate Professor of Urology, Department of Surgery, University of Toronto; Urologic Surgeon, Division of Urology, University Health Network; Fellowship Director, Functional Urology, Toronto Western Hospital; Clinician Investigator, Krembil Research Institute, University Health Network, Toronto, Canada Chair, SIU Innovators, Société Internationale d'Urologie
Disclosures: Astellas, Boston Scientific, Laborie, Medtronic, Olympus, Pierre Fabre Médicament, PROCEPT BioRobotics
Bilal Chughtai, MD
Donald and Barbara Zucker School of Medicine at Hofstra Northwell Health, Syosset, New York, United States
Disclosures: Dr. Chughtai reports receiving grants or research support from Boston Scientific, Bard, Teleflex, Abbvie, and Zenflow. He serves as a consultant for Boston Scientific, Olympus, FemSelect, ARMs, Prodeon Medical, Sumitomo, Teleflex, and Zenflow. Additionally, he is an advisor to Promaxo, Bright Uro, and COSM.
Riccardo Bertolo, MD, PhD
Assistant Professor, University of Verona, Verona, Italy
Disclosures: Receipt of honoraria or consultation fees: Rocamed S.A.M.
Participation in a company sponsored speaker’s bureau: Rocamed S.A.M.
Spouse/partner: Rocamed S.A.M.
Travel honoraria from Elesta S.p.A. and Rocamed S.A.M.
Naeem Bhojani, MD
Associate Professor of Urology, University of Montreal Hospital Center (CHUM), Montreal, Quebec, Canada
Disclosures: Honoraria or consultation fees for Boston Scientific, Laborie, Olympus, PROCEPT BioRobotics.
Mohammed Zain Ulabedin Adhoni, MBBS, MS
The Royal London Hospital, London, United Kingdom
Disclosures:
COMMITTEE 6: Predictive Models—Nomograms for Patient Outcome and Success Criteria
CHAIR
Prof. Stavros Gravas, MD, PhD, FEBU
Professor of Urology, Medical School, University of Cyprus Nicosia, Cyprus; General Secretary, Société Internationale d'Urologie
Disclosures: Grants/research support from Pierre Fabre Médicament; honoraria or consultation fees from Astellas, GSK, Pierre Fabre Médicament.
COMMITTEE MEMBERS
Muhammad Imran Omar, MBBS, MD, MSc, MMEd, FHEA
University of Aberdeen, Aberdeen, United Kingdom; European Association of Urology, Guidelines Office; Cochrane Urology
Disclosures: None
Michael Samarinas, MD
Assistant Professor of Urology, Aristotle University of Thessaloniki, Thessaloniki, Greece
Disclosures: None
Ashani Couchman, MBChB, FRACS (Urol), FUSANZ, GLCP
Urological Surgeon, Royal Adelaide Hospital, Adelaide, South Australia
Disclosures: None
John (Jang-Hwan) Kim, MD, PhD
Professor & Chair, Department of Urology, Yonsei University College of Medicine, Severance Hospital (Yonsei University Health System), Seoul, Republic of Korea
Disclosures: Consultant for Teleflex Korea, Lead Healthcare Korea, Dong-A Pharmaceuticals Korea
Nico C. Grossmann, MD
Swiss Board Certified Urologist; Consultant Urologist, Department of Urology, Kantonsspital Luzern, University of Lucerne, Lucerne, Switzerland
Disclosures: None
Prof. Thorsten Bach, Dr. med., FEBU
Head of Minimal-Invasive Prostate Treatment and Endourology, University Hospital Schleswig-Holstein, Kiel, Germany
Disclosures: None
COMMITTEE 7: Managing Patients with Complications and Persistent Symptoms
CHAIR
Enrico Finazzi Agrò, MD
Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy; Policlinico Tor Vergata, University Hospital, Rome, Italy
Disclosures: Grants/research support from Laborie; honoraria or consultation fees from Recordati, Pierre Fabre Médicament, Convatec; participation in a company sponsored speaker’s bureau for Pierre Fabre Médicament.
COMMITTEE MEMBERS
Anastasios D. Asimakopoulos, MD
Policlinico Tor Vergata, University Hospital, Rome, Italy
Disclosures: None
Stephan Madersbacher, MD
Department of Urology, Klinik Favoriten, Sigmund Freud Private University, Vienna, Austria
Disclosures: None
Mikolaj Przydacz, MD
Department of Urology, Jagiellonian University Medical College, Krakow, Poland
Disclosures: Grants and honoraria from Medtronic, Astellas, Coloplast, and Laborie; Consultant for Medtronic, Astellas, and Coloplast.
Tufan Tarcan, MD
Marmara University School of Medicine and Koç University School of Medicine, Istanbul, Turkey
Disclosures: My potential sources of conflict of interest include consultancy for or receipt of speaker's fees from Viatris, Nobel, Laborie, Recordati, Eczacıbaşı, Abdi Ibrahim, Aymed İlaç.
Eleonora Rosato MD
Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy; Faculty of Medicine and Surgery, University of Rome ‘Tor Vergata’, Rome, Italy
Disclosures: None
COMMITTEE 8: Algorithms for the Management of Male LUTS
CO-CHAIRS
Prof. Stavros Gravas, MD, PhD, FEBU
Professor of Urology, Medical School, University of Cyprus Nicosia, Cyprus; General Secretary, Société Internationale d'Urologie
Disclosures: Grants/research support from Pierre Fabre Médicament; honoraria or consultation fees from Astellas, GSK, Pierre Fabre Médicament.
Dr. Dean Elterman, MD, MSc, FRCSC
Lang Family Endowed Chair in Urologic Innovation; Associate Professor of Urology, Department of Surgery, University of Toronto; Urologic Surgeon, Division of Urology, University Health Network; Fellowship Director, Functional Urology, Toronto Western Hospital; Clinician Investigator, Krembil Research Institute, University Health Network, Toronto, Canada Chair, SIU Innovators, Société Internationale d'Urologie
Disclosures: Astellas, Boston Scientific, Laborie, Medtronic, Olympus, Pierre Fabre Médicament, PROCEPT BioRobotics
Prof. Andrea Tubaro, MD, FEBU
Professor of Urology, Sapienza University of Rome; Chairman, Department of Urology, Sant'Andrea Hospital, Rome, Italy
Disclosures: Receipt of grants/research supports: Johnson&Johnson
Receipt of honoraria or consultation fees: Bayer
Participation in a company sponsored speaker’s bureau: Novo Nordisk
Spouse/partner: Sanofi
